Celularity Inc. (CELU)
1.19
0.03 (2.59%)
At close: Mar 03, 2025, 3:59 PM
1.16
-2.52%
After-hours: Mar 03, 2025, 05:33 PM EST
No 1D chart data available
| Bid | 1.16 |
| Market Cap | 28.33M |
| Revenue (ttm) | 52.22M |
| Net Income (ttm) | -37.97M |
| EPS (ttm) | -100.39 |
| PE Ratio (ttm) | -0.01 |
| Forward PE | -4.33 |
| Analyst | n/a |
| Ask | 1.23 |
| Volume | 270,680 |
| Avg. Volume (20D) | 151,418 |
| Open | 1.15 |
| Previous Close | 1.16 |
| Day's Range | 1.10 - 1.23 |
| 52-Week Range | 1.08 - 7.97 |
| Beta | 0.63 |
About CELU
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-...
Industry Biotechnology
Sector Healthcare
IPO Date Aug 8, 2019
Employees 120
Stock Exchange NASDAQ
Ticker Symbol CELU
Website https://www.celularity.com
3 months ago
+12.6%
Celularity shares are trading higher. The Nasdaq L...
Unlock content with
Pro Subscription
3 months ago
+113.1%
Celularity shares are trading higher after the company announced it raised its FY24 sales guidance from $50-$60M to $54-$60M.
